The ResearchAndMarkets.com platform now includes the “Fetal Doppler Market – Global Outlook & Forecast 2023-2028” report in its offerings. The global fetal Doppler market is poised for significant advancement driven by heightened at-home usage, integration with mobile apps, and a…
Relatient, a premier patient scheduling platform, has clinched the top spot as the Best in KLAS patient self-scheduling solution according to KLAS Research. This prestigious recognition stems from extensive feedback gathered from thousands of providers over the course of 2023.…
The second sentence of the first paragraph of the release should read: “Six studies, presented at the International Stroke Conference (ISC) 2024, have shown positive outcomes with real-world impact of Viz.ai in clinical practice across various neurology pathologies including acute…
Following our previous update on January 5, 2024, we are delighted to share the latest advancements with you. A Phase I dose-ranging clinical trial investigating DFP-14927 in patients with solid tumors has been successfully conducted at MD Anderson Cancer Center…
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology firm specializing in small molecule drugs within virology and immunology, has released its financial results for the fiscal first quarter ending December 31, 2023. The company’s President and Chief Executive Officer, Jay…
Healthmine Welcomes Maureen Sullivan, Former Chief Strategy and Innovation Officer at Blue Cross Blue Shield Association, to Advisory Board Healthmine, a pioneer in technology-driven member engagement solutions, proudly announces the addition of Maureen Sullivan, President of Balestrand Strategic Advisors, to…
UniCare Rebrands as Wellpoint to Emphasize Whole Health Mission UniCare, a health benefits administrator serving over 200,000 Massachusetts state and municipal employees, retirees, and their families, is undergoing a rebranding initiative starting today. The company will now be known as…
BGB Group (BGB), a distinguished healthcare commercialization and communications firm headquartered in New York City with additional offices in Washington DC, Boston, and London, has revealed a strategic partnership with Scrum50 (S50). Scrum50, a dynamic and agile-first creative agency located…
Data from the inaugural US-wide single-center experience at St. Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session during the AF Symposium 2024 in Boston, demonstrates that Left Atrial Appendage Occlusion (LAAO) procedures, strategically planned using FEops…
Edwards Lifesciences Corporation (NYSE: EW) has announced the FDA approval of its EVOQUE tricuspid valve replacement system, marking a groundbreaking achievement as the first transcatheter therapy authorized for treating tricuspid regurgitation (TR) in the United States. The EVOQUE system is…
Unveiling the New Brand: Making its debut at SLAS, Revvity introduces its fresh brand, emphasizing the ongoing commitment to pushing the boundaries of human potential through scientific innovation. The revitalized company showcases a range of specialized technologies and expertise geared…
SCIEX, a renowned global provider of analytical technologies in the life sciences, has unveiled the Echo® MS+ system during SLAS 2024. This cutting-edge system integrates the proprietary Acoustic Ejection Mass Spectrometry technology with Open Port Interface (OPI) sampling, leveraging the…